POPA ReconResearchers found that an experimental Zika vaccine can protect mice through CD8+ T cells even when antibodies provide no protection. A…
Researchers found that an experimental Zika vaccine can protect mice through CD8+ T cells even when antibodies provide no protection. A modified vaccine designed to reduce antibody-dependent enhancement relied entirely on T-cell immunity, but protection disappeared within 12 weeks. The findings suggest future Zika and related flavivirus vaccines may need to generate durable T-cell responses alongside safer antibody immunity. https://www.nature.com/articles/s41564-026-02465-6
The excerpt is quoted from a public Telegram channel, which owns its text.